Atazanavir Sulfate
- Product NDC
- 70518-0946
- 11-digit product format
- 705180946
- Labeler code
- 70518
- Product ID
- 70518-0946_8f6c4a8a-29ba-938b-e053-2a95a90a488c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Atazanavir Sulfate
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA091673
- Marketing category
- ANDA
- Marketing start
- 2018-01-10
- Marketing end
- 0000-00-00
- Substance
- ATAZANAVIR SULFATE
- Active strength
- 300 mg/1
- Pharmacologic classes
- HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC],UGT1A1 Inhibitors [MoA],UDP Glucuronosyltransferases Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 2C8 Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record